The finding of markedly increased monocyte/macrophage activation markers such as MIP-1α and MCP-1 in COVID-19 patients is similar to a previous study describing elevated MIP-1α levels in all COVID-19 patients and elevated MCP-1 values in patients who died (19). This evidence concerns the gene CCL2 and COVID-19.